You are here:

Home
NICE Guidance
Conditions and diseases
Blood and immune system conditions
Blood and bone marrow cancers

Blood and bone marrow cancers Products

A list of all our products on blood and bone marrow cancers

Filter

Product type

Product typeGuidanceQuality standardsAdvice

Guidance programme

Guidance programmeNICE guidelinesTechnology appraisal guidanceDiagnostics guidanceHealthTech guidanceInterventional procedures guidance

Status
1 selected

StatusPublishedIn consultationIn developmentAwaiting developmentTopic prioritisation

New and updated

New and updatedNew in the last 6 monthsUpdated in the last 6 months

Showing 2 products

Sort by: Sort by Date | Title

Status: In consultationRemove ‘Status: In consultation’ filter

Decitabine–cedazuridine with venetoclax for treating acute myeloid leukaemia when intensive induction chemotherapy is unsuitable [ID6601]
Status:
In development | In consultation
Programme:
Technology appraisal guidance
Consultation end date:
11 February 2026
Expected publication date:
TBC
Pirtobrutinib for untreated chronic lymphocytic leukaemia or small lymphocytic lymphoma [ID6397]
Status:
In development | In consultation
Programme:
Technology appraisal guidance
Consultation end date:
11 February 2026
Expected publication date:
TBC